BATS:HELX

Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News

$41.13 -1.38 (-3.25%)
Closing price 04:10 PM Eastern
Extended Trading
$41.17 +0.04 (+0.10%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Franklin Genomic Advancements ETF (BATS:HELX)

Advanced

Key Stats

Today's Range
$41.13
▼
$41.58
50-Day Range
$40.99
▼
$46.01
52-Week Range
$31.24
▼
$46.22
Volume
167 shs
Average Volume
2,861 shs
Market Capitalization
$32.90 million
Assets Under Management
$34.34 million
Dividend Yield
0.34%
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.

Franklin Genomic Advancements ETF Expenses

TypeHELXTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.50%0.57%0.57%0.60%0.53%
Other Expenses0.00%0.57%0.53%0.49%0.54%
Total Expense0.50%0.72%0.75%0.73%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.52%-0.67%
Net Expense0.50%0.60%0.63%0.66%0.60%
Receive HELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HELX ETF News Headlines

(HELX) Franklin Genomic Advancements ETF
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Franklin Genomic Advancements ETF - Markets Insider
Franklin Emerging Markets UCITS ETF (FLXE)
Franklin Ethereum ETF (EZET)
See More Headlines

HELX ETF - Frequently Asked Questions

Franklin Genomic Advancements ETF's stock was trading at $36.35 at the beginning of 2026. Since then, HELX stock has increased by 13.1% and is now trading at $41.13.

Top institutional shareholders of Franklin Genomic Advancements ETF include Harbour Investments Inc. (0.28%).

Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Franklin Templeton Investments
Fund Name
Franklin Genomic Advancements ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:HELX
Inception Date
2/25/2020
Fund Manager
Matthew J.Moberg, Joyce Lin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Constituents
71

Fund Statistics

Assets Under Management
$34.34 million
Average Daily Volume
$0.00
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
Franklin Templeton Services, LLC
Advisor
Franklin Advisers, Inc.
Custodian
The Bank of New York Mellon Corporation
Distributor
Franklin Templeton Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Miscellaneous

Beta
0.97
Creation Unit
50,000
Creation Fee
$200.00
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Top 10 HELX Holdings

HELX Sector Exposure

HELX Industry Exposure


This page (BATS:HELX) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners